|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Advitech Inc., of Quebec, completed the treatment phase in its clinical trial of XP-828L, an orally administered growth factor complex treatment for mild to moderate psoriasis. The main objective was to evaluate the product's efficacy and safety, and Advitech expects to release data July 5.
o American Pharmaceutical Partners Inc., of Schaumburg, Ill., said that a new drug submission for Abraxane was filed with the Therapeutic Products Directorate of Health Canada. The submission seeks Health Canada's approval to market Abraxane in Canada for the treatment of metastatic breast cancer.
o Avantogen Ltd., of Sydney, Australia, said Endocyte Inc., of West ...